Cargando…
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes
Elucidation of physical-chemical characteristics of investigational medicinal products should be established with suitable methodology. Characterization of nanomedicines and nanocarriers in clinical trials may require the definition of additional specific properties depending on the nature of the na...
Autores principales: | Dri, Diego Alejandro, Rinaldi, Federica, Carafa, Maria, Marianecci, Carlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713170/ https://www.ncbi.nlm.nih.gov/pubmed/36450964 http://dx.doi.org/10.1007/s13346-022-01262-y |
Ejemplares similares
-
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials
por: Dri, Diego Alejandro, et al.
Publicado: (2021) -
Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office
por: Dri, Diego Alejandro, et al.
Publicado: (2022) -
Smart Nanovesicles for Drug Targeting and Delivery
por: Marianecci, Carlotta, et al.
Publicado: (2019) -
Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization
por: Tannous, Maria, et al.
Publicado: (2023) -
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office
por: Dri, Diego Alejandro, et al.
Publicado: (2021)